Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Trovagene Inc.
DescriptionMolecular diagnostic test to detect BRAF mutations from cell-free (cf) DNA in urine
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPilot
Standard IndicationCancer, Diagnostic
Indication DetailsDetect BRAF mutation; Monitor metastatic colorectal cancer (mCRC) in patients undergoing therapy
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today